Cough Effectiveness and Pulmonary Hygiene Practices in Patients with Pompe Disease.


Journal

Lung
ISSN: 1432-1750
Titre abrégé: Lung
Pays: United States
ID NLM: 7701875

Informations de publication

Date de publication:
02 2019
Historique:
received: 28 06 2018
accepted: 12 10 2018
pubmed: 27 10 2018
medline: 16 1 2020
entrez: 27 10 2018
Statut: ppublish

Résumé

While factors leading to hypoventilation have been well studied in Pompe disease, cough effectiveness and airway clearance practices are less understood. We aimed to identify significant factors that influence peak cough flow (PCF) in Pompe, and to detect whether pulmonary hygiene practices were reflective of reduced PCF. This is a prospective observational study of 20 subjects with Pompe disease (infantile-onset: 7, juvenile-onset: 6, adult-onset: 14). Subjects performed spirometry, maximal respiratory pressures, and cough (voluntary: n = 24, spontaneous: n = 3). Subjects or their parents reported airway clearance and secretion management practices. Relationships between disease variables, pulmonary function, and cough parameters as well as group differences in cough parameters were evaluated. Subjects with infantile-onset disease had significantly lower PCF (p < 0.05) and tended to require more external ventilatory support (p = 0.07). In juvenile- and adult-onset disease, PCF differed according to external ventilatory requirement [daytime: 83.6 L/min (95% CI 41.2-126.0); nighttime: 224.6 L/min (95% CI 139.1-310.2); none: 340.2 L/min (95% CI 193.3-487.6), p < 0.005]. Cough inspiratory volume also differed significantly by ventilatory requirement [daytime: 5.5 mL/kg (95% CI 3.0-8.0); nighttime: 16.0 mL/kg (95% CI 11.8-20.2); none: 26.8 mL/kg (95% CI 11.9-41.7), p < 0.001]. However, routine airway clearance or secretion management practices were only consistently reported among patients with infantile-onset disease (infantile: 86%, juvenile: 0%, adult: 14%, p < 0.005). Cough weakness was detected in the majority of patients with Pompe disease and was influenced by both inspiratory and expiratory muscle function. Patients at risk for problems or with ineffective PCF should be urged to complete routine pulmonary hygiene.

Identifiants

pubmed: 30361764
doi: 10.1007/s00408-018-0171-1
pii: 10.1007/s00408-018-0171-1
pmc: PMC6366453
mid: NIHMS1510590
doi:

Types de publication

Comparative Study Journal Article Observational Study Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-8

Subventions

Organisme : NICHD NIH HHS
ID : R21 HD090752
Pays : United States

Références

Respir Physiol Neurobiol. 2016 Feb 1;222:11-5
pubmed: 26612101
Ther Clin Risk Manag. 2015 Sep 28;11:1475-88
pubmed: 26451113
Chest. 2015 Nov;148(5):1259-1267
pubmed: 26134718
Am J Phys Med Rehabil. 2008 Jun;87(6):461-7
pubmed: 18496248
Chest. 1996 Dec;110(6):1566-71
pubmed: 8989078
Eur Respir J. 2012 Jun;39(6):1545-6
pubmed: 22654013
Int J Mol Sci. 2016 Oct 17;17(10):
pubmed: 27763517
Thorax. 2012 Jul;67 Suppl 1:i1-40
pubmed: 22730428
Neuromuscul Disord. 2006 May;16(5):325-8
pubmed: 16621559
Respir Care. 2017 Apr;62(4):432-443
pubmed: 28196935
Mol Genet Metab. 2016 Feb;117(2):120-8
pubmed: 26381077
Muscle Nerve. 2009 Jul;40(1):149-60
pubmed: 19533647
J Appl Physiol Respir Environ Exerc Physiol. 1981 Aug;51(2):494-8
pubmed: 7263456
Cochrane Database Syst Rev. 2013 Dec 30;(12):CD010044
pubmed: 24374746
Respir Physiol Neurobiol. 2017 Jun;240:17-25
pubmed: 28213202
Mol Genet Metab. 2013 Nov;110(3):290-6
pubmed: 23916420
Orphanet J Rare Dis. 2017 Mar 16;12(1):52
pubmed: 28302142
Respir Physiol Neurobiol. 2013 Nov 1;189(2):241-9
pubmed: 23797185
Chest. 2006 Jan;129(1 Suppl):48S-53S
pubmed: 16428691
Am J Med Genet C Semin Med Genet. 2012 Feb 15;160C(1):59-68
pubmed: 22253258
Respir Physiol Neurobiol. 2005 Apr 15;146(2-3):291-300
pubmed: 15766917
Eur Respir J. 2005 Aug;26(2):319-38
pubmed: 16055882
Orphanet J Rare Dis. 2015 May 06;10:54
pubmed: 25943355
Chest. 1997 Oct;112(4):1024-8
pubmed: 9377912
Am J Respir Crit Care Med. 2002 Aug 15;166(4):518-624
pubmed: 12186831
Am J Phys Med Rehabil. 2012 Aug;91(8):666-70
pubmed: 22561386
BMC Pulm Med. 2015 May 06;15:54
pubmed: 25943437
Respir Med. 2018 Mar;136:98-110
pubmed: 29501255
Orphanet J Rare Dis. 2011 Jun 01;6:34
pubmed: 21631931
Chest. 2010 May;137(5):1033-9
pubmed: 20040608
Eur Respir J. 2003 Mar;21(3):502-8
pubmed: 12662009

Auteurs

Teresa Pitts (T)

Kentucky Spinal Cord Injury Research Center, University of Louisville, Louisville, KY, USA.

Rachel Bordelon (R)

Department of Osteopathic Medicine, A.T. Still University, Kirksville, MO, USA.

Alyssa Huff (A)

Department of Physiology and Biophysics, University of Louisville, Louisville, KY, USA.

Barry J Byrne (BJ)

Department of Pediatrics, University of Florida, Gainesville, FL, USA.

Barbara K Smith (BK)

Departments of Physical Therapy and Pediatrics, University of Florida, P.O. Box 100154, Gainesville, FL, 32610-0154, USA. bksmith@phhp.ufl.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH